Abstract
Ceftriaxone CTRX was evaluated about its antibacterial activity against clinical isolates at our department and tried clinically in 10 children of 6 months to 10 years and 6 months of age. The antibacterial activity was equal to cefotaxime or higher while the clinical results were almost satisfactory. Three out of 4 strains were eradicated (75%). As to the adverse reaction, eosinophilia was observed only in 1 case.
MeSH terms
-
Bacteria / drug effects
-
Bacterial Infections / drug therapy*
-
Cefotaxime / adverse effects
-
Cefotaxime / analogs & derivatives*
-
Cefotaxime / pharmacology
-
Cefotaxime / therapeutic use
-
Ceftriaxone
-
Child
-
Child, Preschool
-
Drug Evaluation
-
Drug Resistance, Microbial
-
Female
-
Humans
-
Infant
-
Male
-
Respiratory Tract Infections / drug therapy
-
Sepsis / drug therapy
-
Skin Diseases, Infectious / drug therapy
-
Urinary Tract Infections / drug therapy